Alcon (ALC) Depreciation & Amortization (CF) (2009 - 2010)
Alcon (ALC) posted Depreciation & Amortization (CF) of $53.0 million for Q3 2010, little changed on a QoQ basis from $53.0 million in Q2 2010, and up 6.0% year-over-year from $50.0 million in Q3 2009.
Powered by 
Analysis
Alcon (ALC) Depreciation & Amortization (CF) (2009 - 2010) Analysis & Trends
Alcon has reported Depreciation & Amortization (CF) for 2 years, with the latest figure at $53.0 million in Q3 2010.
- On a quarterly basis, Depreciation & Amortization (CF) rose 6.0% year-over-year to $53.0 million in Q3 2010; TTM through Jun 2018 was $53.0 million, a N/A change from a year earlier, with the FY2010 full-year figure at $212.0 million, up 9.28% from the prior year.
- Depreciation & Amortization (CF) was $53.0 million for Q3 2010 at Alcon, roughly flat from $53.0 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $53.0 million in Q2 2010, with the low at $44.0 million in Q1 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | 270.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2010 | 53.00 Mn |
| Jun 30, 2010 | 53.00 Mn |
| Mar 31, 2010 | 51.00 Mn |
| Sep 30, 2009 | 50.00 Mn |
| Jun 30, 2009 | 48.00 Mn |
| Mar 31, 2009 | 44.00 Mn |